Cargando…

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy

Detalles Bibliográficos
Autores principales:	Gong, Ruining, Huang, Yan, Wang, Xiaoxuan, Chen, Xiaobing, Tian, Zibin, Ren, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610156/ https://www.ncbi.nlm.nih.gov/pubmed/34240590 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0406

Ejemplares similares

A path forward to improving the specificity of immunotherapies
por: Barber, Brittany, et al.
Publicado: (2022)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

The path toward editorial quality()
por: Camanho, Gilberto Luis
Publicado: (2014)

Toward integrative cancer immunotherapy: targeting the tumor microenvironment
por: Emens, Leisha A, et al.
Publicado: (2012)

Targeting Innate Immune Cells for Immunotherapy
por: Carreño, Leandro J., et al.
Publicado: (2017)

WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells
por: Chiarugi, Paola
Publicado: (2010)

Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection
por: Ljunggren, Hans‐Gustaf
Publicado: (2020)

Plant immune receptors mimic pathogen virulence targets
por: Sarris, Panagiotis F., et al.
Publicado: (2015)

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
por: Zhang, Ning, et al.
Publicado: (2022)

Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?
por: Lin, Dong, et al.
Publicado: (2016)

The role of p53 in anti-tumor immunity and response to immunotherapy
por: Carlsen, Lindsey, et al.
Publicado: (2023)

Early use of steroids affects immune cells and impairs immunotherapy efficacy
por: Della Corte, Carminia Maria, et al.
Publicado: (2019)

The Immune Response to Tumors as a Tool toward Immunotherapy
por: Pandolfi, F., et al.
Publicado: (2011)

A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma
por: Houchen, Courtney W., et al.
Publicado: (2020)

Immunotherapy for Solid Tumors
por: de Saint Basile, Hortense, et al.
Publicado: (2023)

The New T Cell Subset Opens a New Realm for Tumor Immunotherapy
por: Zhu, Huanjin, et al.
Publicado: (2022)

AURKA inhibition mimics BRCAness
por: Hirst, Jeff, et al.
Publicado: (2017)

Tumor cell plasticity and intrinsic immunogenicity: Implications for immunotherapy resistance in small‐cell lung cancer
por: Ruan, Ji
Publicado: (2021)

Pluripotent stem cell-based therapies and their path to the clinic
por: Takayama, Kazuo, et al.
Publicado: (2023)

Cardiovascular risk assessment: The key path toward precision prevention
por: Li, Jianxin, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is a Stepping Stone in the Path toward Diabetes Mellitus
por: Heo, Nae-Yun
Publicado: (2019)

The Path Forward Toward Health Equity in Radiation Oncology in a Post-2020 Era
por: Deville, Curtiland
Publicado: (2023)

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
por: Tateo, Valentina, et al.
Publicado: (2020)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Path planning and optimization for micro-robot in a vessel-mimic environment
por: Huan, Zhijie, et al.
Publicado: (2022)

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy
por: Sinha, Uttam K., et al.
Publicado: (2023)

Novel Cancer Immunotherapies and Antitumor Immunity
por: Zhao, Lei, et al.
Publicado: (2019)

Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor‐infiltrating immune cell analysis
por: Wan, Yi, et al.
Publicado: (2021)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

T-cell Exhaustion and Cancer Immunotherapy
por: Patil, Shankargouda, et al.
Publicado: (2015)

Advances in Stem Cell Immunotherapy
por: Anderson, Johnathon D
Publicado: (2023)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

The Path of Science
por: Fakharian, Esmaeil
Publicado: (2014)

EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors
por: Li, Dan, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Editorial: Tissue-resident immune cells in tumor immunity and immunotherapy
por: Del Prete, Annalisa, et al.
Publicado: (2022)

Toward long-lasting artificial cells that better mimic natural living cells
por: Yeh Martín, Noël, et al.
Publicado: (2019)

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen
por: Rafiq, S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cji91n3is43bqd3em20018aod5